Immunologic privilege in the central nervous system and the blood–brain barrier

…, GJ Del Zoppo, ND Doolittle… - Journal of Cerebral …, 2013 - journals.sagepub.com
The brain is in many ways an immunologically and pharmacologically privileged site. The
blood–brain barrier (BBB) of the cerebrovascular endothelium and its participation in the …

[HTML][HTML] Current and potential imaging applications of ferumoxytol for magnetic resonance imaging

…, JS Cetas, J Ciporen, TJ DeLoughery, ND Doolittle… - Kidney international, 2017 - Elsevier
Contrast-enhanced magnetic resonance imaging is a commonly used diagnostic tool.
Compared with standard gadolinium-based contrast agents, ferumoxytol (Feraheme, AMAG …

Delivery of chemotherapeutics across the blood–brain barrier: challenges and advances

ND Doolittle, LL Muldoon, AY Culp… - Advances in Pharmacology, 2014 - Elsevier
The blood–brain barrier (BBB) limits drug delivery to brain tumors. We utilize intraarterial
infusion of hyperosmotic mannitol to reversibly open the BBB by shrinking endothelial cells and …

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients …

ND Doolittle, ME Miner, WA Hall, T Siegal, EJ Hanson… - Cancer, 2000 - Wiley Online Library
BACKGROUND The aim of this study was to determine the safety and efficacy of intraarterial
chemotherapy with osmotic opening of the blood‐brain barrier (BBB) for the treatment of …

[HTML][HTML] Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report

…, D Schiff, AJ Hall, TN Shenkier, T Siegal, ND Doolittle… - Annals of oncology, 2007 - Elsevier
Background: Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central
nervous system lymphoma. Because it is rare and difficult to diagnose, the natural history …

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

JR Smith, JT Rosenbaum, DJ Wilson, ND Doolittle… - Ophthalmology, 2002 - Elsevier
PURPOSE: To evaluate the safety and efficacy of intravitreal methotrexate in the management
of primary central nervous system lymphoma (PCNSL) involving the eye. DESIGN: …

[HTML][HTML] Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience

L Angelov, ND Doolittle, DF Kraemer… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Primary CNS lymphoma (PCNSL) is confined to the CNS and/or the eyes at presentation
and is usually initially treated with intravenous methotrexate-based chemotherapy and …

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma

LD McAllister, ND Doolittle, PE Guastadisegni… - …, 2000 - journals.lww.com
OBJECTIVE: Patients with non-acquired immunodeficiency syndrome-related primary central
nervous system lymphomas have the potential to achieve durable complete responses …

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma

ND Doolittle, A Korfel, MA Lubow, E Schorb… - Neurology, 2013 - AAN Enterprises
Objective: To describe and correlate neurotoxicity indicators in long-term primary CNS
lymphoma (PCNSL) survivors who were treated with high-dose methotrexate–based regimens …

Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models

DT Dickey, LL Muldoon, ND Doolittle… - Cancer chemotherapy …, 2008 - Springer
Dosing and route of administration of N-acetylcysteine (NAC) for protection against cisplatin
(CDDP) nephrotoxicity was investigated in rats. Two models of toxicity were tested: a single …